Company / Operating Cash Flow per Share
SELLAS Life Sciences Group, Inc. Operating Cash Flow per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.58
FY2024
5-year range
-$2.05 / -$0.58
FY2020-FY2024
Trend
+61.3%
vs FY2023
Sector context
#106 of 212
Health Care
What the data says
At $-0.58, SELLAS Life Sciences Group, Inc.'s operating cash flow per share ranks #106 of 212 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-116.32 in FY2018 to $-0.44 in FY2015.
Based on SEC 10-K filings.
-0.58 in FY2024.
Improved from $-1.64 to $-0.58 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#106 of 212 in Health CareTop 50% of 212This company -$0.58 Sector average -$14.72
▼
+96.1% above sector average
Key checks
Key Insights
- In FY2024, operating cash flow per share increased 61.3% year-over-year.
- Ranks #106 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2015.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$0.58 | +61.3% |
| FY2023 | -$1.50 | +8.7% |
| FY2022 | -$1.64 | -124.0% |
| FY2021 | -$0.73 | +64.4% |
| FY2020 | -$2.05 | +70.3% |
| FY2019 | -$6.90 | +94.1% |
| FY2018 | -$116.32 | -2377.3% |
| FY2017 | -$4.70 | -220.8% |
| FY2016 | -$1.46 | -232.6% |
| FY2015 | -$0.44 | -12.3% |
As of FY2024 · SEC 10-K · Updated Jun 30, 2026